CD Biosynsis offers advanced CRISPR Interference (CRISPRi) services for highly tunable and reversible gene repression in Pseudomonas putida. As a powerful metabolic engineering chassis, P. putida often requires fine-tuning of gene expression—not just complete knockout—to balance metabolic fluxes, prevent accumulation of toxic intermediates, or study essential gene functions. Our CRISPRi platform utilizes catalytically inactive Cas9 (dCas9) guided by single guide RNA (sgRNA) to block transcription initiation or elongation. This strategy enables precise, titratable knockdown of target genes, providing unparalleled control over metabolic pathways for strain optimization and fundamental biological research.
Get a QuoteIn many metabolic engineering scenarios, the complete removal of an enzyme (gene knockout) is detrimental, especially if the enzyme is part of a complex regulatory network or an essential pathway. CRISPRi provides the ideal solution by offering "tunable suppression." The system allows for gene expression levels to be adjusted—ranging from mild suppression to near-complete repression—simply by modulating the concentration of the inducer (e.g., anhydrotetracycline) controlling dCas9 expression. This precise control is critical for relieving metabolic bottlenecks, balancing the expression of multi-gene pathways, and performing flux optimization in P. putida hosts.
Catalytically Inactive
Cas9 is mutated to retain its DNA binding capability but lose its nuclease activity (HNH and RuvC domains are inactivated). It binds but does not cleave the target DNA.
Inducible Expression
dCas9 expression is typically controlled by an inducible promoter (e.g., Tet or rhamnose system) to allow precise control over the repression strength.
Targeting Region
The sgRNA is designed to guide dCas9 to a specific sequence within the target gene's promoter region or the early coding sequence.
Repression Mechanism
Binding of the large dCas9 protein physically blocks RNA polymerase from initiating transcription (promoter targeting) or blocks the ribosome (coding region targeting).
Titratable Knockdown
Repression level correlates directly with the concentration of the inducer used to express dCas9, allowing for precise metabolic flux control.
Reversibility
Removing the inducer allows dCas9 expression to cease, reversing the repression effect and restoring native gene expression quickly.
We provide a streamlined service from target selection to validated, tunable strains.
1. Design & Vector Construction
2. Delivery & Strain Integration
3. Repression Tuning Assay
4. Functional Validation
Selection of optimal sgRNA target sequence to achieve maximal repression.
Cloning of sgRNA into a suitable expression vector (often co-expressed with dCas9).
Preparation of the dCas9 expression cassette (inducible system).
Co-delivery of the dCas9 and sgRNA components into the P. putida strain (plasmid-based or genomic integration).
Selection for successful transformants under appropriate conditions.
Phenotype Assessment: Analyzing the impact of tuned repression on growth rate and product titer.
Deliver the final validated CRISPRi strain with a comprehensive dose-response curve and protocol for tunable repression.
Metabolic Flux Balancing
Slowing down over-active enzymes or competing pathways to prevent intermediate accumulation and optimize downstream product synthesis.
Essential Gene Study
Creating viable "hypomorph" strains (low expression mutants) of essential genes to study their function without causing cell death.
Optimization of Inducible Promoters
Repressing leaky expression from inducible promoters in the "OFF" state to ensure tight control in production phases.
Multiplex Regulation
Simultaneously tuning the expression levels of multiple genes in the same pathway using an array of specific sgRNAs.
Precise Tunability
We provide a validated dose-response curve, enabling researchers to achieve the exact desired level of gene repression for flux control.
Reversibility and Speed
The repressive effect is quickly reversed upon inducer removal, which is ideal for studying dynamic cellular responses and optimizing fermentation timing.
Minimal Off-Target Effects
Optimized sgRNA design and use of dCas9 ensure high specificity and reduce unintended repression of non-target genes.
How is CRISPRi different from gene knockout?
Gene knockout permanently eliminates the gene function (0% expression). CRISPRi causes tunable repression, meaning the expression can be reduced to any level between 10% and 90% of the native expression, and this effect is reversible.
Is the dCas9 component integrated into the P. putida genome?
We can offer both plasmid-based and genomic integration solutions. Genomic integration of the dCas9 cassette offers greater long-term stability but slightly lower copy number than a stable plasmid.
Can CRISPRi target multiple genes simultaneously?
Yes. By expressing multiple sgRNAs from a single plasmid or operon, we can guide dCas9 to repress several target genes simultaneously, which is essential for rebalancing complex metabolic fluxes.
What kind of control system is typically used for dCas9?
We typically use tightly controlled, low-leakage inducible systems such as the Tet-inducible system (using anhydrotetracycline, aTc) or the rhamnose-inducible system, which are well-established for reliable gene control in P. putida.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.